Related Experiment Video
Updated: Jul 11, 2026
11:34
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
Opportunities for treating chronic hepatitis B and C virus infection using RNA interference
P Arbuthnot1, V Longshaw, T Naidoo
1Hepatitis B Virus Research Unit, Department of Molecular Medicine and Haematology, University of the Witwatersrand Medical School, Johannesburg, South Africa. arbuthnotpb@pathology.wits.ac.za
Journal of Viral Hepatitis
|June 20, 2007
Summary
RNA interference (RNAi) offers a promising new strategy for treating chronic hepatitis B and C infections by silencing viral genes. This review explores RNAi
Area of Science:
- Molecular Biology
- Virology
- Gene Silencing
Background:
- Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are major global causes of liver cirrhosis and cancer.
- Current treatments for HBV and HCV have limitations, necessitating novel therapeutic approaches.
- RNA interference (RNAi) is a powerful molecular mechanism for targeted gene silencing.
Purpose of the Study:
- To review the potential of RNA interference (RNAi) as a therapeutic strategy against chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections.
- To summarize existing research demonstrating the efficacy of RNAi in inhibiting HBV and HCV.
- To discuss the challenges and future directions for developing RNAi-based therapies for viral hepatitis.
Main Methods:
- Review of in vitro and in vivo studies investigating RNAi-mediated silencing of HBV and HCV.
- Analysis of the application of RNAi activators for inhibiting viral gene expression.
- Discussion of the challenges in translating RNAi technology to clinical applications.
Main Results:
- Evidence from multiple studies demonstrates the proof of principle for inhibiting HBV and HCV using RNAi activators.
- In vitro and in vivo investigations confirm the potential of RNAi to reduce viral gene expression.
- Successful gene silencing of HBV and HCV has been achieved in experimental settings.
Conclusions:
- RNA interference (RNAi) presents a significant therapeutic potential for treating chronic HBV and HCV infections.
- Further development is required to overcome challenges and advance RNAi-based therapies towards clinical application.
- Targeted gene silencing via RNAi offers a promising avenue for novel antiviral treatments.
More Related Videos
Related Concept Videos
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:29Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...